Abstract
The aspartate analog 2-amino-3-phosphonopropionic acid (AP3) antagonizes glutamate-stimulated phosphatidyl inositide hydrolysis in brain slices, but is reportedly weak or ineffective in antagonizing the phosphatidyl inositide-coupled cloned metabotropic glutamate receptors 1α and 5. Thus we examined the pharmacological properties of AP3 on mGlu1α and mGlu5 receptor responses in Xenopus oocytes. DL-AP3 antagonized mGlu1α and mGlu5 responses, but antagonism was overcome at high glutamate concentrations consistent with competitive inhibition (IC50 = 2.1 nM for mGlu1α). Both responses were also inhibited by (RS)-α-methyl-4-carboxyphenylglycine (MCPG). We conclude that the available antagonists cannot distinguish between the mGlu1α receptor and mGlu5 receptor, and that antagonism by AP3 may be obscured in the presence of high agonist concentrations or in cells with spare receptors.
Original language | English (US) |
---|---|
Pages (from-to) | 395-397 |
Number of pages | 3 |
Journal | European Journal of Pharmacology: Molecular Pharmacology |
Volume | 289 |
Issue number | 2 |
DOIs | |
State | Published - Apr 28 1995 |
Keywords
- L-AP3 (L-2-amino-3-phosphonopropionic acid)
- MCPG ((RS)-α-methyl-4-carboxyphenylglycine)
- Metabotropic glutamate receptor
- Phosphatidyl inositide hydrolysis
- Xenopus oocyte
ASJC Scopus subject areas
- Pharmacology